A Single Arm Phase 2 Study of Talimogene Laherparepvec in Patients with Low-Risk Invasive Cutaneous Squamous Cell Cancer. Interim Analysis.
Journal of Clinical Oncology(2022)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要
Journal of Clinical Oncology(2022)